Loading
A phase 3 trial of sintilimab, carboplatin and nab-paclitaxel in lung cancer, run by Second Affiliated Hospital, Zhejiang University, School of Medicine, now recruiting.
Neoadjuvant Therapy of Sintilimab Combined With Chemotherapy for Resectable Squamous Cell NSCLC（neoSCORE II） is a phase 3, randomised interventional study registered as NCT05429463 by Second Affiliated Hospital, Zhejiang University, School of Medicine, with a registry enrolment figure of 250 participants, started 2022-11-11 and due to reach its primary completion in 2025-11-11. Interventions recorded: Sintilimab; Carboplatin; Albumin-Bound Paclitaxel. Conditions listed: Squamous Cell Non-small Cell Lung Cancer. Primary outcome: Major pathological response rate (MPR). Lung eligibility wording from the registry: "Squamous Cell Non-small cell lung cancer confirmed by cytology or histology". Sites: China. No results are recorded here; the registry entry is the source.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Resectable stage I to III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot), Platinum agents, Carboplatin and the tag lung-deep-dive.
Shares Nab-paclitaxel, Lung cancer trials open today (registry snapshot), Platinum agents, Carboplatin and the tag lung-deep-dive.
Shares Nab-paclitaxel, Lung cancer trials open today (registry snapshot), Platinum agents, Carboplatin and the tag lung-deep-dive.
Shares Nab-paclitaxel, Lung cancer trials open today (registry snapshot), Platinum agents, Carboplatin and the tag lung-deep-dive.
Shares Resectable stage I to III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot), Platinum agents, Carboplatin and the tag lung-deep-dive.
Shares Nab-paclitaxel, Lung cancer trials open today (registry snapshot), Platinum agents, Carboplatin and the tag lung-deep-dive.
Shares Nab-paclitaxel, Lung cancer trials open today (registry snapshot), Platinum agents, Carboplatin and the tag lung-deep-dive.
Shares Resectable stage I to III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot), Platinum agents, Carboplatin and the tag lung-deep-dive.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/